Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance

Published:2021-09 Issue:3 Volume:1 Page:75-87
ISSN:2667-0054
Container-title:Journal of the National Cancer Center
language:en
Short-container-title:Journal of the National Cancer Center

Author:

Bai Xupeng,Ni Jie,Beretov Julia,Graham Peter^ORCID,Li Yong

Publisher

Elsevier BV

Reference83 articles.

1. Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer;Karn;JAMA Oncol,2017

2. Guestini F, McNamara KM, Ishida T, et al. Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification. Expert Opin Ther Targets. Jun 2016;20(6):705-20. doi:10.1517/14728222.2016.1125469

3. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation;Robson;N Engl J Med,2017

4. Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?;Bai;Cancer Lett,2021

5. PD-L1 expression in triple-negative breast cancer;Mittendorf;Cancer Immunol Res,2014

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An immunoinformatics approach for a potential NY-ESO-1 and WT1 based multi-epitope vaccine designing against triple-negative breast cancer;Heliyon;2024-09

2. Role of WAVE3 as an actin binding protein in the pathology of triple negative breast cancer;Cytoskeleton;2024-07-18

3. Advances in Monoclonal Antibody Therapies for Triple-Negative Breast Cancer: Immunotherapeutic and Targeted Strategies;Current Molecular Medicine;2024-01-26

4. ROR2 promotes invasion and chemoresistance of triple-negative breast cancer cells by activating PI3K/AKT/mTOR signaling;Oncology Research;2024

5. Nanotechnology Applications in Breast Cancer Immunotherapy;Small;2023-12-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3